vs
Byrna Technologies Inc.（BYRN）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Byrna Technologies Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.8倍（$35.2M vs $19.6M），Byrna Technologies Inc.净利率更高（9.5% vs -177.4%，领先187.0%），Byrna Technologies Inc.同比增速更快（26.0% vs -11.5%），Byrna Technologies Inc.自由现金流更多（$8.1M vs $-23.1M），过去两年Byrna Technologies Inc.的营收复合增速更高（45.5% vs -12.2%）
Byrna Technologies Inc.是一家专注于非致命个人安全及自卫产品研发、生产与销售的企业，核心产品包括手持式动能发射器、专用非致命投射弹及相关配件，服务个人消费者、执法机构、私营安保公司及教育机构，核心市场覆盖北美并正拓展全球布局。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
BYRN vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $35.2M | $19.6M |
| 净利润 | $3.4M | $-34.7M |
| 毛利率 | 59.8% | 48.5% |
| 营业利润率 | 11.2% | -168.5% |
| 净利率 | 9.5% | -177.4% |
| 营收同比 | 26.0% | -11.5% |
| 净利润同比 | -65.2% | -28.8% |
| 每股收益（稀释后） | $0.14 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $35.2M | — | ||
| Q3 25 | $28.2M | $19.6M | ||
| Q2 25 | $28.5M | $21.8M | ||
| Q1 25 | $26.2M | $40.8M | ||
| Q4 24 | $28.0M | — | ||
| Q3 24 | $20.9M | $22.1M | ||
| Q2 24 | $20.3M | $22.5M | ||
| Q1 24 | $16.7M | $45.5M |
| Q4 25 | $3.4M | — | ||
| Q3 25 | $2.2M | $-34.7M | ||
| Q2 25 | $2.4M | $-33.5M | ||
| Q1 25 | $1.7M | $-26.0M | ||
| Q4 24 | $9.7M | — | ||
| Q3 24 | $1.0M | $-26.9M | ||
| Q2 24 | $2.1M | $-45.7M | ||
| Q1 24 | $17.0K | $-32.2M |
| Q4 25 | 59.8% | — | ||
| Q3 25 | 60.1% | 48.5% | ||
| Q2 25 | 61.6% | 48.8% | ||
| Q1 25 | 60.8% | 48.4% | ||
| Q4 24 | 62.8% | — | ||
| Q3 24 | 62.4% | 54.9% | ||
| Q2 24 | 62.0% | 46.1% | ||
| Q1 24 | 57.9% | 53.1% |
| Q4 25 | 11.2% | — | ||
| Q3 25 | 10.2% | -168.5% | ||
| Q2 25 | 11.7% | -118.1% | ||
| Q1 25 | 6.5% | -80.8% | ||
| Q4 24 | 14.6% | — | ||
| Q3 24 | 4.0% | -120.9% | ||
| Q2 24 | 9.4% | -134.5% | ||
| Q1 24 | -1.0% | -132.2% |
| Q4 25 | 9.5% | — | ||
| Q3 25 | 7.9% | -177.4% | ||
| Q2 25 | 8.5% | -153.7% | ||
| Q1 25 | 6.3% | -63.8% | ||
| Q4 24 | 34.6% | — | ||
| Q3 24 | 4.9% | -122.0% | ||
| Q2 24 | 10.2% | -203.3% | ||
| Q1 24 | 0.1% | -70.6% |
| Q4 25 | $0.14 | — | ||
| Q3 25 | $0.09 | $-0.09 | ||
| Q2 25 | $0.10 | $-0.09 | ||
| Q1 25 | $0.07 | $-0.07 | ||
| Q4 24 | $0.42 | — | ||
| Q3 24 | $0.04 | $-0.07 | ||
| Q2 24 | $0.09 | $-0.12 | ||
| Q1 24 | $0.00 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $65.8M | $399.7M |
| 总资产 | $84.5M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $15.5M | — | ||
| Q3 25 | $9.0M | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | $19.3M | $150.9M | ||
| Q4 24 | $25.7M | — | ||
| Q3 24 | $20.1M | $210.6M | ||
| Q2 24 | $24.8M | $269.8M | ||
| Q1 24 | $24.2M | $287.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
| Q4 25 | $65.8M | — | ||
| Q3 25 | $63.1M | $399.7M | ||
| Q2 25 | $60.1M | $424.5M | ||
| Q1 25 | $56.8M | $454.6M | ||
| Q4 24 | $54.4M | — | ||
| Q3 24 | $44.5M | $489.3M | ||
| Q2 24 | $45.3M | $510.3M | ||
| Q1 24 | $43.2M | $577.3M |
| Q4 25 | $84.5M | — | ||
| Q3 25 | $78.6M | $539.6M | ||
| Q2 25 | — | $557.0M | ||
| Q1 25 | $71.0M | $579.6M | ||
| Q4 24 | $71.9M | — | ||
| Q3 24 | $59.0M | $681.5M | ||
| Q2 24 | $57.5M | $708.7M | ||
| Q1 24 | $52.7M | $777.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | $-23.1M |
| 自由现金流率自由现金流/营收 | 23.1% | -118.1% |
| 资本支出强度资本支出/营收 | 5.1% | 4.5% |
| 现金转化率经营现金流/净利润 | 2.95× | — |
| 过去12个月自由现金流最近4个季度 | $-9.2M | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $9.9M | — | ||
| Q3 25 | $-2.3M | $-22.2M | ||
| Q2 25 | $-5.5M | $-20.7M | ||
| Q1 25 | $-3.8M | $-30.3M | ||
| Q4 24 | $7.3M | — | ||
| Q3 24 | $-1.4M | $-27.9M | ||
| Q2 24 | $1.9M | $-39.0M | ||
| Q1 24 | $3.9M | $-62.5M |
| Q4 25 | $8.1M | — | ||
| Q3 25 | $-4.5M | $-23.1M | ||
| Q2 25 | $-6.4M | $-22.6M | ||
| Q1 25 | $-6.4M | $-35.3M | ||
| Q4 24 | $6.3M | — | ||
| Q3 24 | $-2.1M | $-30.1M | ||
| Q2 24 | $1.4M | $-41.0M | ||
| Q1 24 | $3.8M | $-63.3M |
| Q4 25 | 23.1% | — | ||
| Q3 25 | -16.0% | -118.1% | ||
| Q2 25 | -22.4% | -103.6% | ||
| Q1 25 | -24.5% | -86.6% | ||
| Q4 24 | 22.5% | — | ||
| Q3 24 | -10.0% | -136.4% | ||
| Q2 24 | 7.0% | -182.2% | ||
| Q1 24 | 22.6% | -138.9% |
| Q4 25 | 5.1% | — | ||
| Q3 25 | 8.0% | 4.5% | ||
| Q2 25 | 3.3% | 8.7% | ||
| Q1 25 | 10.1% | 12.4% | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 3.3% | 10.2% | ||
| Q2 24 | 2.6% | 8.6% | ||
| Q1 24 | 1.0% | 1.7% |
| Q4 25 | 2.95× | — | ||
| Q3 25 | -1.01× | — | ||
| Q2 25 | -2.25× | — | ||
| Q1 25 | -2.27× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | -1.36× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 231.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BYRN
| E Commerce | $23.0M | 65% |
| Wholesale Dealerdistributors | $10.9M | 31% |
| Other | $1.3M | 4% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
